Tongmei Zhang

Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute

SCHOLARLY PAPERS

2

DOWNLOADS

123

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Intergration of Clinical and Blood Parameters in Risk Prognostication for Patients Receiving Immunochemotherapy for Extensive Stage Small Cell Lung Cancer: Real-World Data from Two Centers

Number of pages: 29 Posted: 30 Jan 2024
Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University - Cancer Centre, Shaanxi Hospital of Traditional Chinese Medicine, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University - Cancer Centre, Capital Medical University - Cancer Centre, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute and Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute
Downloads 78 (676,624)

Abstract:

Loading...

extensive stage small cell lung cancer, immunochemotherapy, real-world studies, predictive models, biomarkers

2.

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer

Number of pages: 42 Posted: 01 Jun 2021
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Chinese Academy of Medical Sciences - State Key Lab of Molecular Oncology, Geneplus-Beijing Co. Ltd. - Medical Center, Geneplus-Beijing Co. Ltd. - Medical Center, Capital Medical University - Department of Respiratory and Critical Care Medicine, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, Geneplus-Beijing Co. Ltd., Geneplus-Beijing Institute, Geneplus-Beijing Institute, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs
Downloads 45 (895,370)

Abstract:

Loading...

Small-cell lung cancer; Molecular tumor burden index; Circulating tumor DNA sequencing; Progression-free survival; Predictive classifiers